The world's leading journal on infectious diseases. Clinical ID, public health, microbiology, and everything in-between. Official publication of @IDSAinfo
Adherence to Hepatocellular Carcinoma Surveillance Guidelines Among People With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection
β Just Accepted
π bit.ly/3S5brKF
SARS-CoV-2 vaccination and attenuation of breakthrough infection severity: A systematic global review and meta-analysis
β Just Accepted
π bit.ly/3QEn2jn
Markers of immune function and survival among cancer patients with HIV in the United States: a population-based registry linkage study
β Just Accepted
βοΈ @camcanepibit.ly/4dLWZQa
Efficacy and acceptability of liraglutide for obesity in people with HIV: results of an open-label clinical trial in South Africa
β Just Accepted
bit.ly/4vPAgJa
Donβt Drop the B: Risk of Hepatitis B Virus Infection and Reactivation in the Era of Tenofovir-Sparing Regimens for Treatment and Prevention of HIV
β Just Accepted
βοΈ @HowardTLeeMD
π bit.ly/3RXJXXg
Early Discontinuation of Empiric Antibiotics in Pediatric Haploidentical Hematopoietic Cell Transplant Recipients with Febrile Neutropenia
β Just Accepted
βοΈ @StJudeResearchbit.ly/4umVnBd
What if Goldilocks Had a Choice? Rethinking the Optimal Duration of Empiric Antibiotics in Pediatric Hematopoietic Cell Transplant Recipients with Persistent Fever and Neutropenia
β Just Accepted
π bit.ly/4v3mZww
The latest CID supplement issue highlights the clinical and research framework needed to combat antimicrobial resistance and accelerate progress in antibiotic development.
βͺοΈ bit.ly/4xgx8r2
Prevalence and Outcomes of Bacterial Co-detections by Blood Culture Among Children and Adults Hospitalized With Laboratory-confirmed Influenza, Influenza Hospitalization Surveillance Network, 2022β2024
β Just Accepted
π bit.ly/4xbASKr